Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating

Neuropsychopharmacology

Volumn 36, Issue 5, 2011, Pages 1003-1014

  Alsene, Karen M ^a   Rajbhandari, Abha K ^a   Ramaker, Marcia J ^b   Bakshi, Vaishali P ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

antipsychotic; attention; limbic; locus ceruleus; noradrenaline; norepinephrine

Indexed keywords

ISOPRENALINE; PHENYLEPHRINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FOREBRAIN; HIPPOCAMPUS; MALE; NERVE CELL NETWORK; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SENSORY GATING; SIGNAL TRANSDUCTION; STRIA TERMINALIS; THALAMUS;

ACOUSTIC STIMULATION; ADRENERGIC AGENTS; AMYGDALA; ANIMALS; BRAIN MAPPING; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; HIPPOCAMPUS; MALE; NEURAL INHIBITION; NEURAL PATHWAYS; NOREPINEPHRINE; PROSENCEPHALON; PSYCHOACOUSTICS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; SENSORY GATING; STARTLE REACTION;

EID: 79952749707     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.238     Document Type: Article

References (89)

1. Alelu-Paz R, Gimenez-Amaya JM (2008). The mediodorsal thalamic nucleus and schizophrenia. J Psychiatry Neurosci 33: 489-498.
2. Alsene KM, Carasso BS, Connors EE, Bakshi VP (2006). Disruption of prepulse inhibition after stimulation of central but not peripheral alpha-1 adrenergic receptors. Neuropsychopharma-cology 31: 2150-2161. (Pubitemid 44413192)
3. Arnsten AF (2004). Adrenergic targets for the treatment of cognitive deficits in schizophrenia. Psychopharmacology (Berl) 174: 25-31. (Pubitemid 38925087)
4. Arnsten AF, Mathew R, Ubriani R, Taylor JR, Li BM (1999). Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol Psychiatry 45: 26-31. (Pubitemid 29049201)
5. Arnsten AF, Steere JC, Jentsch DJ, Li BM (1998). Noradrenergic influences on prefrontal cortical cognitive function: opposing actions at postjunctional alpha 1 vs alpha 2-adrenergic receptors. Adv Pharmacol 42: 764-767.
6. Aston-Jones G, Cohen JD (2005). Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol 493: 99-110. (Pubitemid 41637975)
7. Azami NS, Piri M, Oryan S, Jahanshahi M, Babapour V, Zarrindast MR (2010). Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol Learn Mem 93: 455-462.
8. Bakshi VP, Alsene KM (2010). Locus coeruleus: A novel substrate in the regulation of sensorimotor gating. Neuropsychopharma-cology 35: S292.
9. Baldo BA, Daniel RA, Berridge CW, Kelley AE (2003). Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydro-xylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 464: 220-237. (Pubitemid 36976049)
10. Berridge CW (2008). Noradrenergic modulation of arousal. Brain Res Rev 58: 1-17.
11. Berridge CW, Isaac SO, Espana RA (2003). Additive wake-promoting actions of medial basal forebrain noradrenergic alpha1- and beta-receptor stimulation. Behav Neurosci 117: 350-359. (Pubitemid 36384253)
12. Berridge CW, Stratford TL, Foote SL, Kelley AE (1997). Distribution of dopamine beta-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27: 230-241. (Pubitemid 27430672)
13. Berridge CW, Waterhouse BD (2003). The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Brain Res Rev 42: 33-84. (Pubitemid 36369264)
14. Bhidayasiri R (2005). Tourette's syndrome: old syndrome, new insights and new treatment. J Med Assoc Thai 88(Suppl 4): S339-S347.
15. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234-258. (Pubitemid 32705488)
16. Braff DL, Greenwood TA, Swerdlow NR, Light GA, Schork NJ (2008). Advances in endophenotyping schizophrenia. World Psychiatry 7: 11-18. (Pubitemid 351338180)
17. Breier A, Wolkowitz OM, Roy A, Potter WZ, Pickar D (1990). Plasma norepinephrine in chronic schizophrenia. Am J Psychiatry 147: 1467-1470. (Pubitemid 20365434)
18. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP et al (1994). International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121-136.
19. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC et al (1996). Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14: 87-96. (Pubitemid 26053226)
20. Byne W, Hazlett EA, Buchsbaum MS, Kemether E (2009). The thalamus and schizophrenia: current status of research. Acta Neuropathol 117: 347-368.
21. Carasso BS, Bakshi VP, Geyer MA (1998). Disruption in prepulse inhibition after alpha-1 adrenoceptor stimulation in rats. Neuropharmacology 37: 401-404. (Pubitemid 28282646)
22. Castellanos FX, Fine EJ, Kaysen D, Marsh WL, Rapoport JL, Hallett M (1996). Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 39: 33-41. (Pubitemid 26022681)
23. Daly CM, Doyle ME, Radkind M, Raskind E, Daniels C (2005). Clinical case series: the use of Prazosin for combat-related recurrent nightmares among Operation Iraqi Freedom combat veterans. Mil Med 170: 513-515. (Pubitemid 40814242)
24. Delfs JM, Zhu Y, Druhan JP, Aston-Jones GS (1998). Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens: anterograde and retrograde tract-tracing studies in the rat. Brain Res 806: 127-140. (Pubitemid 29010488)
25. Dvorakova M, Jezova D, Blazicek P, Trebaticka J, Skodacek I, Suba J et al (2007). Urinary catecholamines in children with attention deficit hyperactivity disorder (ADHD): modulation by a polyphenolic extract from pine bark (pycnogenol). Nutr Neurosci 10: 151-157. (Pubitemid 47490014)
26. Fendt M, Li L, Yeomans JS (2001). Brain stem circuits mediating prepulse inhibition of the startle reflex. Psychopharmacology (Berl) 156: 216-224. (Pubitemid 32702214)
27. Ferry B, Roozendaal B, McGaugh JL (1999). Involvement of alpha1-adrenoceptors in the basolateral amygdala in modulation of memory storage. Eur J Pharmacol 372: 9-16. (Pubitemid 29229858)
28. Foote SL, Bloom FE, Aston-Jones G (1983). Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63: 844-914. (Pubitemid 13048718)
29. Gabbott PL, Warner TA, Jays PR, Salway P, Busby SJ (2005). Prefrontal cortex in the rat: projections to subcortical auto-nomic, motor, and limbic centers. J Comp Neurol 492: 145-177. (Pubitemid 41443719)
30. Gay N, Cottraux JA, Denoroy L, Tommasi M, Kopp N (1989). Possible increase of dopamine-beta-hydroxylase activity in the locus ceruleus of paranoid schizophrenic patients: a preliminary post-mortem study. Psychiatry Res 27: 31-38. (Pubitemid 19042423)
31. Geyer MA (2008). Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res 14: 71-78.
32. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156: 117-154. (Pubitemid 32702206)
33. Geyer MA, Swerdlow NR, Mansbach RS, Braff DL (1990). Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25: 485-498. (Pubitemid 20346586)
34. Giguere M, Goldman-Rakic PS (1988). Mediodorsal nucleus: areal, laminar, and tangential distribution of afferents and efferents in the frontal lobe of rhesus monkeys. J Comp Neurol 277: 195-213. (Pubitemid 19002131)
35. Gomes UC, Shanley BC, Potgieter L, Roux JT (1980). Noradrener-gic overactivity in chronic schizophrenia: evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations. Br J Psychiatry 137: 346-351. (Pubitemid 11243355)
36. Grasso C, Li Volsi G, Licata F, Ciranna L, Santangelo F (2006). Aminergic control of neuronal firing rate in thalamic motor nuclei of the rat. Arch Ital Biol 144: 173-196. (Pubitemid 44448270)
37. Grillon C, Morgan CA, Southwick SM, Davis M, Charney DS (1996). Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder. Psychiatry Res 64: 169-178. (Pubitemid 26380236)
38. Hoover WB, Vertes RP (2007). Anatomical analysis of afferent projections to the medial prefrontal cortex in the rat. Brain Struct Funct 212: 149-179. (Pubitemid 47394494)
39. Hornykiewicz O (1982). Brain catecholamines in schizophreniaFa good case for noradrenaline. Nature 299: 484-486.
40. Kerfoot EC, Chattillion EA, Williams CL (2008). Functional interactions between the nucleus tractus solitarius (NTS) and nucleus accumbens shell in modulating memory for arousing experiences. Neurobiol Learn Mem 89: 47-60. (Pubitemid 350102250)
41. Kobayashi M (2007). Differential regulation of synaptic transmission by adrenergic agonists via protein kinase A and protein kinase C in layer V pyramidal neurons of rat cerebral cortex. Neuroscience 146: 1772-1784. (Pubitemid 46783236)
42. Koch M, Kungel M, Herbert H (1993). Cholinergic neurons in the pedunculopontine tegmental nucleus are involved in the mediation of prepulse inhibition of the acoustic startle response in the rat. Exp Brain Res 97: 71-82. (Pubitemid 24045423)
43. Kodsi MH, Swerdlow NR (1997). Regulation of prepulse inhibition by ventral pallidal projections. Brain Res Bull 43: 219-228. (Pubitemid 27284065)
44. Kuroda M (1998). Synaptic connections between the prefrontal cortex and the mediodorsal nucleus of the thalamus. Kaibogaku Zasshi 73: 93-106. (Pubitemid 128738083)
45. Lahdesmaki J, Sallinen J, MacDonald E, Kobilka BK, Fagerholm V, Scheinin M (2002). Behavioral and neurochemical characterization of alpha(2A)-adrenergic receptor knockout mice. Neuroscience 113: 289-299. (Pubitemid 34786174)
46. Lahdesmaki J, Sallinen J, MacDonald E, Scheinin M (2004). Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. Neuropsychopharmacology 29: 1282-1293. (Pubitemid 38780651)
47. Lapiz MD, Morilak DA (2006). Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137: 1039-1049. (Pubitemid 43053965)
48. Leckman JF, Goodman WK, Anderson GM, Riddle MA, Chappell PB, McSwiggan-Hardin MT et al (1995). Cerebrospinal fluid biogenic amines in obsessive compulsive disorder, Tourette's syndrome, and healthy controls. Neuropsychopharmacology 12: 73-86.
49. Leckman JF, Hardin MT, Riddle MA, Stevenson J, Ort SI, Cohen DJ (1991). Clonidine treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 48: 324-328.
50. Lewis DA (2009). Neuroplasticity of excitatory and inhibitory cortical circuits in schizophrenia. Dialogues Clin Neurosci 11: 269-280.
51. Mansbach RS, Geyer MA, Braff DL (1988). Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychophar-macology (Berl) 94: 507-514. (Pubitemid 18087401)
52. McCormick DA, Pape HC, Williamson A (1991). Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog Brain Res 88: 293-305.
53. McCune SK, Voigt MM, Hill JM (1993). Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain. Neuroscience 57: 143-151. (Pubitemid 23325639)
54. Melchitzky DS, Lewis DA (2001). Dopamine transporter-immu-noreactive axons in the mediodorsal thalamic nucleus of the macaque monkey. Neuroscience 103: 1033-1042. (Pubitemid 32289313)
55. Miranda MA, Ferry B, Ferreira G (2007). Basolateral amygdala noradrenergic activity is involved in the acquisition of conditioned odor aversion in the rat. Neurobiol Learn Mem 88: 260-263. (Pubitemid 47223754)
56. Miyashita T, Ichinohe N, Rockland KS (2007). Differential modes of termination of amygdalothalamic and amygdalocortical projections in the monkey. J Comp Neurol 502: 309-324. (Pubitemid 46595401)
57. Montagnese CM, Mezey SE, Csillag A (2003). Efferent connections of the dorsomedial thalamic nuclei of the domestic chick (Gallus domesticus). J Comp Neurol 459: 301-326. (Pubitemid 36384312)
58. Moxon KA, Devilbiss DM, Chapin JK, Waterhouse BD (2007). Influence of norepinephrine on somatosensory neuronal responses in the rat thalamus: a combined modeling and in vivo multi-channel, multi-neuron recording study. Brain Res 1147: 105-123. (Pubitemid 46584661)
59. Nicholas AP, Hokfelt T, Pieribone VA (1996). The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol Sci 17: 245-255. (Pubitemid 26233105)
60. Pakkenberg B, Scheel-Kruger J, Kristiansen LV (2009). Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop. Acta Psychiatr Scand 120: 345-354.
61. Palacios J, Kuhar MJ (1982). Beta adrenergic receptor localization in rat brain by light microscopic autoradiography. Neurochem Int 4: 473-490. (Pubitemid 13201555)
62. Pieribone VA, Nicholas AP, Dagerlind A, Hokfelt T (1994). Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes. J Neurosci 14: 4252-4268.
63. Pupo AS, Minneman KP (2001). Adrenergic pharmacology: focus on the central nervous system. CNS Spectr 6: 656-662. (Pubitemid 34546963)
64. Rainbow TC, Parsons B, Wolfe BB (1984). Quantitative autoradio-graphy of beta 1- and beta 2-adrenergic receptors in rat brain. Proc Natl Acad Sci USA 81: 1585-1589. (Pubitemid 14174548)
65. Ramos BP, Colgan L, Nou E, Ovadia S, Wilson SR, Arnsten AF (2005). The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biol Psychiatry 58: 894-900. (Pubitemid 41790718)
66. Ramos BP, Stark D, Verduzco L, van Dyck CH, Arnsten AF (2006). Alpha2A-adrenoceptor stimulation improves prefrontal cortical regulation of behavior through inhibition of cAMP signaling in aging animals. Learn Mem 13: 770-776. (Pubitemid 44871678)
67. Robbins TW, Arnsten AF (2009). The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32: 267-287.
68. Rommelfanger KS, Mitrano DA, Smith Y, Weinshenker D (2009). Light and electron microscopic localization of alpha-1 adrener-gic receptor immunoreactivity in the rat striatum and ventral midbrain. Neuroscience 158: 1530-1540.
69. Roozendaal B, Castello NA, Vedana G, Barsegyan A, McGaugh JL (2008). Noradrenergic activation of the basolateral amygdala modulates consolidation of object recognition memory. Neurobiol Learn Mem 90: 576-579.
70. Roozendaal B, Hahn EL, Nathan SV, de Quervain DJ, McGaugh JL (2004). Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J Neurosci 24: 8161-8169. (Pubitemid 39280836)
71. Rotaru DC, Barrionuevo G, Sesack SR (2005). Mediodorsal thalamic afferents to layer III of the rat prefrontal cortex: synaptic relationships to subclasses of interneurons. J Comp Neurol 490: 220-238. (Pubitemid 41140990)
72. Sallinen J, Haapalinna A, Viitamaa T, Kobilka BK, Scheinin M (1998). Adrenergic alpha2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J Neurosci 18: 3035-3042. (Pubitemid 28163233)
73. Sandyk R (1986). Tourette syndrome: a case for noradrenergic and opiatergic mechanisms. Int J Neurosci 30: 303-309.
74. Sara SJ (2009). The locus coeruleus and noradrenergic modulation of cognition. Nat Rev Neurosci 10: 211-223.
75. Schwabe K, Koch M (2004). Role of the medial prefrontal cortex in N-methyl-D-aspartate receptor antagonist induced sensorimotor gating deficit in rats. Neurosci Lett 355: 5-8. (Pubitemid 38077171)
76. Southwick SM, Krystal JH, Morgan CA, Johnson D, Nagy LM, Nicolaou A et al (1993). Abnormal noradrenergic function in posttraumatic stress disorder. Arch Gen Psychiatry 50: 266-274. (Pubitemid 23115369)
77. Strazielle C, Lalonde R, Hebert C, Reader TA (1999). Regional brain distribution of noradrenaline uptake sites, and of alpha1-alpha2- and beta-adrenergic receptors in PCD mutant mice: a quantitative autoradiographic study. Neuroscience 94: 287-304. (Pubitemid 29457619)
78. Swanson LW, Hartman BK (1975). The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J Comp Neurol 163: 467-505.
79. Swerdlow NR (2001). Obsessive-compulsive disorder and tic syndromes. Med Clin North Am 85: 735-755. (Pubitemid 32397224)
80. Swerdlow NR, Bongiovanni MJ, Tochen L, Shoemaker JM (2006). Separable noradrenergic and dopaminergic regulation of pre-pulse inhibition in rats: implications for predictive validity and Tourette syndrome. Psychopharmacology (Berl) 186: 246-254. (Pubitemid 43727342)
81. Swerdlow NR, Geyer MA, Braff DL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156: 194-215. (Pubitemid 32702213)
82. Swerdlow NR, Pitcher L, Noh HR, Shoemaker JM (2002). Startle gating in rats is disrupted by chemical inactivation but not D2 stimulation of the dorsomedial thalamus. Brain Res 953: 246-254. (Pubitemid 35217826)
83. Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008). Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology (Berl) 199: 331-388.
84. Terenzi MG, Ingram CD (1995). A combined immunocytochemical and retrograde tracing study of noradrenergic connections between the caudal medulla and bed nuclei of the stria terminalis. Brain Res 672: 289-297.
85. Varty GB, Bakshi VP, Geyer MA (1999). M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats. Neuropsychopharmacology 20: 311-321. (Pubitemid 29099762)
86. Verheij MM, Cools AR (2009). Accumbal noradrenaline that contributes to the alpha-adrenoceptor-mediated release of dopamine from reserpine-sensitive storage vesicles in the nucleus accumbens is derived from alpha-methyl-para- tyro-sine-sensitive pools. J Neural Transm 116: 389-394.
87. Vertes RP, Hoover WB, Szigeti-Buck K, Leranth C (2007). Nucleus reuniens of the midline thalamus: link between the medial prefrontal cortex and the hippocampus. Brain Res Bull 71: 601-609. (Pubitemid 46209526)
88. Watanabe Y, Ikegaya Y, Saito H, Abe K (1996). Opposite regulation by the beta-adrenoceptor-cyclic AMP system of synaptic plasticity in the medial and lateral amygdala in vitro. Neuroscience 71: 1031-1035.
89. Young III WS, Kuhar MJ (1980). Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization. Proc Natl Acad Sci USA 77: 1696-1700. (Pubitemid 10067422)